Wisconsin researchers receive $60 million from NIH for All of Us research program
Four Wisconsin medical and scientific organizations – Marshfield Clinic Research Institute, University of Wisconsin School of Medicine and Public Health, Froedtert & the Medical College of Wisconsin and BloodCenter of Wisconsin, part of Versiti – were awarded $60 million by the National Institutes of Health (NIH) to continue to implement the All of Us Research Program in Wisconsin through 2023, a momentous effort to advance individualized prevention, treatment and care for people of all backgrounds.
UW Carbone Cancer Center study to look for ways to personalize therapy in colorectal cancer
A five-year, $3 million grant from the National Cancer Institute will support UW Carbone Cancer Center physician-researcher Dusty Deming, MD, and colleagues in their pursuit of more effective treatments for colorectal-cancer patients.
Myeloma vaccine research earns $600,000 Leukemia and Lymphoma Society grant
UW Carbone Cancer Center hematologist and myeloma researcher Fotis Asimakopoulos, MD, PhD, was awarded a Leukemia and Lymphoma Society grant to identify patients mostly likely to benefit from a personalized cancer vaccine.
Researchers team up to find new therapies for childhood MDS, leukemia
Two researchers from the University of Wisconsin School of Medicine and Public Health will join forces to discover how a particular gene could affect a deadly, rare childhood genetic disease.
Wisconsin researchers awarded $5.3 million for NIH precision medicine research
Three Wisconsin based medical and scientific organizations – Marshfield Clinic Research Institute, University of Wisconsin School of Medicine and Public Health and Medical College of Wisconsin – have collectively been awarded $5,360,832 to help implement in Wisconsin the National Institutes of Health’s (NIH’s) All of Us Research Program that aims to benefit communities across the country.
Stephen Meyn to lead Center for Human Genomics and Precision Medicine
As the University of Wisconsin School of Medicine and Public Health embarks on its strategic plan to build a world-class, state-of-the-art precision medicine and genomics center, it has begun the process by choosing its first director.